APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Systemic Antifungals

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Systemic Antifungals Market Analysis and Forecast 2026-2032

Report ID 174039290230 December 2025201 pages

Choose your research edition.

Industry ResearchSystemic Antifungals Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Systemic Antifungals Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Systemic Antifungals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Systemic Antifungals Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Systemic Antifungals Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Systemic Antifungals market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Systemic Antifungals is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Systemic Antifungals is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Systemic Antifungals is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Systemic Antifungals is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Systemic Antifungals include MSD, Zhuhai Ebang Pharmaceutical, Chiatai Tianqing, Xian-janssen, Novartis, Merck, Livzon Group Livzon Pharmaceutical Factory, Honz Pharmaceutical and Pfizer, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Systemic Antifungals, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Systemic Antifungals, also provides the revenue of main regions and countries. Of the upcoming market potential for Systemic Antifungals, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Systemic Antifungals revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Systemic Antifungals market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Systemic Antifungals revenue, projected growth trends, production technology, application and end-user industry.

Systemic Antifungals Segment by Company

MSD

Zhuhai Ebang Pharmaceutical

Chiatai Tianqing

Xian-janssen

Novartis

Merck

Livzon Group Livzon Pharmaceutical Factory

Honz Pharmaceutical

Pfizer

CR Pharma

Haisco Pharmaceutical

Medisan

Chengdu Brilliant Pharmaceutical

Bayer

Liposome Company

Gilead Sciences

Astellas Pharma

Systemic Antifungals Segment by Type

Injections

Oral

Systemic Antifungals Segment by Application

Clinic

Hospital

Drugstores

Others

Systemic Antifungals Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Systemic Antifungals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Systemic Antifungals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Systemic Antifungals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Systemic Antifungals in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Systemic Antifungals company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Systemic Antifungals revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Systemic Antifungals Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Injections Major Player Table 3. Oral Major Player Table 4. Global Systemic Antifungals Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Clinic Major Player Table 6. Hospital Major Player Table 7. Drugstores Major Player Table 8. Others Major Player Table 9. Systemic Antifungals Industry Trends Table 10. Systemic Antifungals Industry Drivers Table 11. Systemic Antifungals Industry Opportunities and Challenges Table 12. Systemic Antifungals Industry Restraints Table 13. Global Systemic Antifungals Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Systemic Antifungals Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Systemic Antifungals Market Share by Region (2021-2026) Table 16. Global Systemic Antifungals Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Systemic Antifungals Market Share by Region (2027-2032) Table 18. Global Systemic Antifungals Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Systemic Antifungals Revenue Market Share by Players (2021-2026) Table 20. Global Systemic Antifungals Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Systemic Antifungals Key Players Headquarters & Area Served Table 22. Global Systemic Antifungals Players, Product Type & Application Table 23. Global Systemic Antifungals Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Systemic Antifungals by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Systemic Antifungals Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Systemic Antifungals Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Systemic Antifungals Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Systemic Antifungals Revenue Market Share by Type (2021-2026) Table 30. Global Systemic Antifungals Revenue Market Share by Type (2027-2032) Table 31. Global Systemic Antifungals Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Systemic Antifungals Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Systemic Antifungals Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Systemic Antifungals Revenue Market Share by Application (2021-2026) Table 35. Global Systemic Antifungals Revenue Market Share by Application (2027-2032) Table 36. MSD Company Information Table 37. MSD Business Overview Table 38. MSD Systemic Antifungals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. MSD Systemic Antifungals Product Portfolio Table 40. MSD Recent Development Table 41. Zhuhai Ebang Pharmaceutical Company Information Table 42. Zhuhai Ebang Pharmaceutical Business Overview Table 43. Zhuhai Ebang Pharmaceutical Systemic Antifungals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Zhuhai Ebang Pharmaceutical Systemic Antifungals Product Portfolio Table 45. Zhuhai Ebang Pharmaceutical Recent Development Table 46. Chiatai Tianqing Company Information Table 47. Chiatai Tianqing Business Overview Table 48. Chiatai Tianqing Systemic Antifungals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Chiatai Tianqing Systemic Antifungals Product Portfolio Table 50. Chiatai Tianqing Recent Development Table 51. Xian-janssen Company Information Table 52. Xian-janssen Business Overview Table 53. Xian-janssen Systemic Antifungals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Xian-janssen Systemic Antifungals Product Portfolio Table 55. Xian-janssen Recent Development Table 56. Novartis Company Information Table 57. Novartis Business Overview Table 58. Novartis Systemic Antifungals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Novartis Systemic Antifungals Product Portfolio Table 60. Novartis Recent Development Table 61. Merck Company Information Table 62. Merck Business Overview Table 63. Merck Systemic Antifungals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Merck Systemic Antifungals Product Portfolio Table 65. Merck Recent Development Table 66. Livzon Group Livzon Pharmaceutical Factory Company Information Table 67. Livzon Group Livzon Pharmaceutical Factory Business Overview Table 68. Livzon Group Livzon Pharmaceutical Factory Systemic Antifungals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Livzon Group Livzon Pharmaceutical Factory Systemic Antifungals Product Portfolio Table 70. Livzon Group Livzon Pharmaceutical Factory Recent Development Table 71. Honz Pharmaceutical Company Information Table 72. Honz Pharmaceutical Business Overview Table 73. Honz Pharmaceutical Systemic Antifungals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Honz Pharmaceutical Systemic Antifungals Product Portfolio Table 75. Honz Pharmaceutical Recent Development Table 76. Pfizer Company Information Table 77. Pfizer Business Overview Table 78. Pfizer Systemic Antifungals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Pfizer Systemic Antifungals Product Portfolio Table 80. Pfizer Recent Development Table 81. CR Pharma Company Information Table 82. CR Pharma Business Overview Table 83. CR Pharma Systemic Antifungals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. CR Pharma Systemic Antifungals Product Portfolio Table 85. CR Pharma Recent Development Table 86. Haisco Pharmaceutical Company Information Table 87. Haisco Pharmaceutical Business Overview Table 88. Haisco Pharmaceutical Systemic Antifungals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Haisco Pharmaceutical Systemic Antifungals Product Portfolio Table 90. Haisco Pharmaceutical Recent Development Table 91. Medisan Company Information Table 92. Medisan Business Overview Table 93. Medisan Systemic Antifungals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Medisan Systemic Antifungals Product Portfolio Table 95. Medisan Recent Development Table 96. Chengdu Brilliant Pharmaceutical Company Information Table 97. Chengdu Brilliant Pharmaceutical Business Overview Table 98. Chengdu Brilliant Pharmaceutical Systemic Antifungals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Chengdu Brilliant Pharmaceutical Systemic Antifungals Product Portfolio Table 100. Chengdu Brilliant Pharmaceutical Recent Development Table 101. Bayer Company Information Table 102. Bayer Business Overview Table 103. Bayer Systemic Antifungals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Bayer Systemic Antifungals Product Portfolio Table 105. Bayer Recent Development Table 106. Liposome Company Company Information Table 107. Liposome Company Business Overview Table 108. Liposome Company Systemic Antifungals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Liposome Company Systemic Antifungals Product Portfolio Table 110. Liposome Company Recent Development Table 111. Gilead Sciences Company Information Table 112. Gilead Sciences Business Overview Table 113. Gilead Sciences Systemic Antifungals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Gilead Sciences Systemic Antifungals Product Portfolio Table 115. Gilead Sciences Recent Development Table 116. Astellas Pharma Company Information Table 117. Astellas Pharma Business Overview Table 118. Astellas Pharma Systemic Antifungals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Astellas Pharma Systemic Antifungals Product Portfolio Table 120. Astellas Pharma Recent Development Table 121. North America Systemic Antifungals Revenue by Type (2021-2026) & (US$ Million) Table 122. North America Systemic Antifungals Revenue by Type (2027-2032) & (US$ Million) Table 123. North America Systemic Antifungals Revenue by Application (2021-2026) & (US$ Million) Table 124. North America Systemic Antifungals Revenue by Application (2027-2032) & (US$ Million) Table 125. North America Systemic Antifungals Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. North America Systemic Antifungals Revenue by Country (2021-2026) & (US$ Million) Table 127. North America Systemic Antifungals Revenue by Country (US$ Million) & (2027-2032) Table 128. Europe Systemic Antifungals Revenue by Type (2021-2026) & (US$ Million) Table 129. Europe Systemic Antifungals Revenue by Type (2027-2032) & (US$ Million) Table 130. Europe Systemic Antifungals Revenue by Application (2021-2026) & (US$ Million) Table 131. Europe Systemic Antifungals Revenue by Application (2027-2032) & (US$ Million) Table 132. Europe Systemic Antifungals Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Europe Systemic Antifungals Revenue by Country (2021-2026) & (US$ Million) Table 134. Europe Systemic Antifungals Revenue by Country (US$ Million) & (2027-2032) Table 135. China Systemic Antifungals Revenue by Type (2021-2026) & (US$ Million) Table 136. China Systemic Antifungals Revenue by Type (2027-2032) & (US$ Million) Table 137. China Systemic Antifungals Revenue by Application (2021-2026) & (US$ Million) Table 138. China Systemic Antifungals Revenue by Application (2027-2032) & (US$ Million) Table 139. Asia Systemic Antifungals Revenue by Type (2021-2026) & (US$ Million) Table 140. Asia Systemic Antifungals Revenue by Type (2027-2032) & (US$ Million) Table 141. Asia Systemic Antifungals Revenue by Application (2021-2026) & (US$ Million) Table 142. Asia Systemic Antifungals Revenue by Application (2027-2032) & (US$ Million) Table 143. Asia Systemic Antifungals Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Asia Systemic Antifungals Revenue by Region (US$ Million) & (2021-2026) Table 145. Asia Systemic Antifungals Revenue by Region (US$ Million) & (2027-2032) Table 146. SAMEA Systemic Antifungals Revenue by Type (2021-2026) & (US$ Million) Table 147. SAMEA Systemic Antifungals Revenue by Type (2027-2032) & (US$ Million) Table 148. SAMEA Systemic Antifungals Revenue by Application (2021-2026) & (US$ Million) Table 149. SAMEA Systemic Antifungals Revenue by Application (2027-2032) & (US$ Million) Table 150. SAMEA Systemic Antifungals Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. SAMEA Systemic Antifungals Revenue by Country (2021-2026) & (US$ Million) Table 152. SAMEA Systemic Antifungals Revenue by Country (US$ Million) & (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Systemic Antifungals Image Figure 2. Global Systemic Antifungals Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Systemic Antifungals Market Size Share 2021 VS 2025 VS 2032 Figure 4. Injections Image Figure 5. Oral Image Figure 6. Global Systemic Antifungals Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Systemic Antifungals Market Size Share 2021 VS 2025 VS 2032 Figure 8. Clinic Image Figure 9. Hospital Image Figure 10. Drugstores Image Figure 11. Others Image Figure 12. Global Systemic Antifungals Market Size (US$ Million) & (2021-2032) Figure 13. Global Systemic Antifungals Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Systemic Antifungals Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Systemic Antifungals Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Systemic Antifungals Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Systemic Antifungals Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Systemic Antifungals Revenue Market Share by Type (2021-2032) Figure 20. Global Systemic Antifungals Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Systemic Antifungals Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Systemic Antifungals Revenue Market Share by Application (2021-2032) Figure 23. North America Systemic Antifungals Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Systemic Antifungals Revenue Share by Type (2021-2032) Figure 25. North America Systemic Antifungals Revenue Share by Application (2021-2032) Figure 26. North America Systemic Antifungals Revenue Share by Country (2021-2032) Figure 27. United States Systemic Antifungals Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Systemic Antifungals Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Systemic Antifungals Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Systemic Antifungals Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Systemic Antifungals Revenue Share by Type (2021-2032) Figure 32. Europe Systemic Antifungals Revenue Share by Application (2021-2032) Figure 33. Europe Systemic Antifungals Revenue Share by Country (2021-2032) Figure 34. Germany Systemic Antifungals Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Systemic Antifungals Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Systemic Antifungals Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Systemic Antifungals Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Systemic Antifungals Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Systemic Antifungals Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Systemic Antifungals Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Systemic Antifungals Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Systemic Antifungals Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Systemic Antifungals Revenue Share by Type (2021-2032) Figure 44. China Systemic Antifungals Revenue Share by Application (2021-2032) Figure 45. Asia Systemic Antifungals Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Systemic Antifungals Revenue Share by Type (2021-2032) Figure 47. Asia Systemic Antifungals Revenue Share by Application (2021-2032) Figure 48. Asia Systemic Antifungals Revenue Share by Region (2021-2032) Figure 49. Japan Systemic Antifungals Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Systemic Antifungals Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Systemic Antifungals Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Systemic Antifungals Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Systemic Antifungals Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Systemic Antifungals Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Systemic Antifungals Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Systemic Antifungals Revenue Share by Type (2021-2032) Figure 57. SAMEA Systemic Antifungals Revenue Share by Application (2021-2032) Figure 58. SAMEA Systemic Antifungals Revenue Share by Country (2021-2032) Figure 59. Brazil Systemic Antifungals Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Systemic Antifungals Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Systemic Antifungals Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Systemic Antifungals Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Systemic Antifungals Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Systemic Antifungals Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Systemic Antifungals Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Systemic Antifungals Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Systemic Antifungals Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Systemic Antifungals Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Systemic Antifungals Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Injections
  • Oral
Applications
  • Clinic
  • Hospital
  • Drugstores
  • Others
Companies covered
  • MSD
  • Zhuhai Ebang Pharmaceutical
  • Chiatai Tianqing
  • Xian-janssen
  • Novartis
  • Merck
  • Livzon Group Livzon Pharmaceutical Factory
  • Honz Pharmaceutical
  • Pfizer
  • CR Pharma
  • Haisco Pharmaceutical
  • Medisan
  • Chengdu Brilliant Pharmaceutical
  • Bayer
  • Liposome Company
  • Gilead Sciences
  • Astellas Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Systemic Antifungals Market by Type
  3. 1.2.1 Global Systemic Antifungals Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Injections
  5. 1.2.3 Oral
  6. 1.3 Systemic Antifungals Market by Application
  7. 1.3.1 Global Systemic Antifungals Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Clinic
  9. 1.3.3 Hospital
  10. 1.3.4 Drugstores
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Systemic Antifungals Market Dynamics
  1. 2.1 Systemic Antifungals Industry Trends
  2. 2.2 Systemic Antifungals Industry Drivers
  3. 2.3 Systemic Antifungals Industry Opportunities and Challenges
  4. 2.4 Systemic Antifungals Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Systemic Antifungals Market Perspective (2021-2032)
  2. 3.2 Global Systemic Antifungals Growth Trends by Region
  3. 3.2.1 Global Systemic Antifungals Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Systemic Antifungals Market Size by Region (2021-2026)
  5. 3.2.3 Global Systemic Antifungals Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Systemic Antifungals Revenue by Players
  2. 4.1.1 Global Systemic Antifungals Revenue by Players (2021-2026)
  3. 4.1.2 Global Systemic Antifungals Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Systemic Antifungals Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Systemic Antifungals Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Systemic Antifungals Key Players Headquarters & Area Served
  7. 4.4 Global Systemic Antifungals Players, Product Type & Application
  8. 4.5 Global Systemic Antifungals Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Systemic Antifungals Market CR5 and HHI
  11. 4.6.3 2025 Systemic Antifungals Tier 1, Tier 2, and Tier 3
5 Systemic Antifungals Market Size by Type
  1. 5.1 Global Systemic Antifungals Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Systemic Antifungals Revenue by Type (2021-2032)
  3. 5.3 Global Systemic Antifungals Revenue Market Share by Type (2021-2032)
6 Systemic Antifungals Market Size by Application
  1. 6.1 Global Systemic Antifungals Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Systemic Antifungals Revenue by Application (2021-2032)
  3. 6.3 Global Systemic Antifungals Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 MSD
  2. 7.1.1 MSD Company Information
  3. 7.1.2 MSD Business Overview
  4. 7.1.3 MSD Systemic Antifungals Revenue and Gross Margin (2021-2026)
  5. 7.1.4 MSD Systemic Antifungals Product Portfolio
  6. 7.1.5 MSD Recent Developments
  7. 7.2 Zhuhai Ebang Pharmaceutical
  8. 7.2.1 Zhuhai Ebang Pharmaceutical Company Information
  9. 7.2.2 Zhuhai Ebang Pharmaceutical Business Overview
  10. 7.2.3 Zhuhai Ebang Pharmaceutical Systemic Antifungals Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Zhuhai Ebang Pharmaceutical Systemic Antifungals Product Portfolio
  12. 7.2.5 Zhuhai Ebang Pharmaceutical Recent Developments
  13. 7.3 Chiatai Tianqing
  14. 7.3.1 Chiatai Tianqing Company Information
  15. 7.3.2 Chiatai Tianqing Business Overview
  16. 7.3.3 Chiatai Tianqing Systemic Antifungals Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Chiatai Tianqing Systemic Antifungals Product Portfolio
  18. 7.3.5 Chiatai Tianqing Recent Developments
  19. 7.4 Xian-janssen
  20. 7.4.1 Xian-janssen Company Information
  21. 7.4.2 Xian-janssen Business Overview
  22. 7.4.3 Xian-janssen Systemic Antifungals Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Xian-janssen Systemic Antifungals Product Portfolio
  24. 7.4.5 Xian-janssen Recent Developments
  25. 7.5 Novartis
  26. 7.5.1 Novartis Company Information
  27. 7.5.2 Novartis Business Overview
  28. 7.5.3 Novartis Systemic Antifungals Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Novartis Systemic Antifungals Product Portfolio
  30. 7.5.5 Novartis Recent Developments
  31. 7.6 Merck
  32. 7.6.1 Merck Company Information
  33. 7.6.2 Merck Business Overview
  34. 7.6.3 Merck Systemic Antifungals Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Merck Systemic Antifungals Product Portfolio
  36. 7.6.5 Merck Recent Developments
  37. 7.7 Livzon Group Livzon Pharmaceutical Factory
  38. 7.7.1 Livzon Group Livzon Pharmaceutical Factory Company Information
  39. 7.7.2 Livzon Group Livzon Pharmaceutical Factory Business Overview
  40. 7.7.3 Livzon Group Livzon Pharmaceutical Factory Systemic Antifungals Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Livzon Group Livzon Pharmaceutical Factory Systemic Antifungals Product Portfolio
  42. 7.7.5 Livzon Group Livzon Pharmaceutical Factory Recent Developments
  43. 7.8 Honz Pharmaceutical
  44. 7.8.1 Honz Pharmaceutical Company Information
  45. 7.8.2 Honz Pharmaceutical Business Overview
  46. 7.8.3 Honz Pharmaceutical Systemic Antifungals Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Honz Pharmaceutical Systemic Antifungals Product Portfolio
  48. 7.8.5 Honz Pharmaceutical Recent Developments
  49. 7.9 Pfizer
  50. 7.9.1 Pfizer Company Information
  51. 7.9.2 Pfizer Business Overview
  52. 7.9.3 Pfizer Systemic Antifungals Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Pfizer Systemic Antifungals Product Portfolio
  54. 7.9.5 Pfizer Recent Developments
  55. 7.10 CR Pharma
  56. 7.10.1 CR Pharma Company Information
  57. 7.10.2 CR Pharma Business Overview
  58. 7.10.3 CR Pharma Systemic Antifungals Revenue and Gross Margin (2021-2026)
  59. 7.10.4 CR Pharma Systemic Antifungals Product Portfolio
  60. 7.10.5 CR Pharma Recent Developments
  61. 7.11 Haisco Pharmaceutical
  62. 7.11.1 Haisco Pharmaceutical Company Information
  63. 7.11.2 Haisco Pharmaceutical Business Overview
  64. 7.11.3 Haisco Pharmaceutical Systemic Antifungals Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Haisco Pharmaceutical Systemic Antifungals Product Portfolio
  66. 7.11.5 Haisco Pharmaceutical Recent Developments
  67. 7.12 Medisan
  68. 7.12.1 Medisan Company Information
  69. 7.12.2 Medisan Business Overview
  70. 7.12.3 Medisan Systemic Antifungals Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Medisan Systemic Antifungals Product Portfolio
  72. 7.12.5 Medisan Recent Developments
  73. 7.13 Chengdu Brilliant Pharmaceutical
  74. 7.13.1 Chengdu Brilliant Pharmaceutical Company Information
  75. 7.13.2 Chengdu Brilliant Pharmaceutical Business Overview
  76. 7.13.3 Chengdu Brilliant Pharmaceutical Systemic Antifungals Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Chengdu Brilliant Pharmaceutical Systemic Antifungals Product Portfolio
  78. 7.13.5 Chengdu Brilliant Pharmaceutical Recent Developments
  79. 7.14 Bayer
  80. 7.14.1 Bayer Company Information
  81. 7.14.2 Bayer Business Overview
  82. 7.14.3 Bayer Systemic Antifungals Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Bayer Systemic Antifungals Product Portfolio
  84. 7.14.5 Bayer Recent Developments
  85. 7.15 Liposome Company
  86. 7.15.1 Liposome Company Company Information
  87. 7.15.2 Liposome Company Business Overview
  88. 7.15.3 Liposome Company Systemic Antifungals Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Liposome Company Systemic Antifungals Product Portfolio
  90. 7.15.5 Liposome Company Recent Developments
  91. 7.16 Gilead Sciences
  92. 7.16.1 Gilead Sciences Company Information
  93. 7.16.2 Gilead Sciences Business Overview
  94. 7.16.3 Gilead Sciences Systemic Antifungals Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Gilead Sciences Systemic Antifungals Product Portfolio
  96. 7.16.5 Gilead Sciences Recent Developments
  97. 7.17 Astellas Pharma
  98. 7.17.1 Astellas Pharma Company Information
  99. 7.17.2 Astellas Pharma Business Overview
  100. 7.17.3 Astellas Pharma Systemic Antifungals Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Astellas Pharma Systemic Antifungals Product Portfolio
  102. 7.17.5 Astellas Pharma Recent Developments
8 North America
  1. 8.1 North America Systemic Antifungals Revenue (2021-2032)
  2. 8.2 North America Systemic Antifungals Revenue by Type (2021-2032)
  3. 8.2.1 North America Systemic Antifungals Revenue by Type (2021-2026)
  4. 8.2.2 North America Systemic Antifungals Revenue by Type (2027-2032)
  5. 8.3 North America Systemic Antifungals Revenue Share by Type (2021-2032)
  6. 8.4 North America Systemic Antifungals Revenue by Application (2021-2032)
  7. 8.4.1 North America Systemic Antifungals Revenue by Application (2021-2026)
  8. 8.4.2 North America Systemic Antifungals Revenue by Application (2027-2032)
  9. 8.5 North America Systemic Antifungals Revenue Share by Application (2021-2032)
  10. 8.6 North America Systemic Antifungals Revenue by Country
  11. 8.6.1 North America Systemic Antifungals Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Systemic Antifungals Revenue by Country (2021-2026)
  13. 8.6.3 North America Systemic Antifungals Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Systemic Antifungals Revenue (2021-2032)
  2. 9.2 Europe Systemic Antifungals Revenue by Type (2021-2032)
  3. 9.2.1 Europe Systemic Antifungals Revenue by Type (2021-2026)
  4. 9.2.2 Europe Systemic Antifungals Revenue by Type (2027-2032)
  5. 9.3 Europe Systemic Antifungals Revenue Share by Type (2021-2032)
  6. 9.4 Europe Systemic Antifungals Revenue by Application (2021-2032)
  7. 9.4.1 Europe Systemic Antifungals Revenue by Application (2021-2026)
  8. 9.4.2 Europe Systemic Antifungals Revenue by Application (2027-2032)
  9. 9.5 Europe Systemic Antifungals Revenue Share by Application (2021-2032)
  10. 9.6 Europe Systemic Antifungals Revenue by Country
  11. 9.6.1 Europe Systemic Antifungals Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Systemic Antifungals Revenue by Country (2021-2026)
  13. 9.6.3 Europe Systemic Antifungals Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Systemic Antifungals Revenue (2021-2032)
  2. 10.2 China Systemic Antifungals Revenue by Type (2021-2032)
  3. 10.2.1 China Systemic Antifungals Revenue by Type (2021-2026)
  4. 10.2.2 China Systemic Antifungals Revenue by Type (2027-2032)
  5. 10.3 China Systemic Antifungals Revenue Share by Type (2021-2032)
  6. 10.4 China Systemic Antifungals Revenue by Application (2021-2032)
  7. 10.4.1 China Systemic Antifungals Revenue by Application (2021-2026)
  8. 10.4.2 China Systemic Antifungals Revenue by Application (2027-2032)
  9. 10.5 China Systemic Antifungals Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Systemic Antifungals Revenue (2021-2032)
  2. 11.2 Asia Systemic Antifungals Revenue by Type (2021-2032)
  3. 11.2.1 Asia Systemic Antifungals Revenue by Type (2021-2026)
  4. 11.2.2 Asia Systemic Antifungals Revenue by Type (2027-2032)
  5. 11.3 Asia Systemic Antifungals Revenue Share by Type (2021-2032)
  6. 11.4 Asia Systemic Antifungals Revenue by Application (2021-2032)
  7. 11.4.1 Asia Systemic Antifungals Revenue by Application (2021-2026)
  8. 11.4.2 Asia Systemic Antifungals Revenue by Application (2027-2032)
  9. 11.5 Asia Systemic Antifungals Revenue Share by Application (2021-2032)
  10. 11.6 Asia Systemic Antifungals Revenue by Country
  11. 11.6.1 Asia Systemic Antifungals Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Systemic Antifungals Revenue by Country (2021-2026)
  13. 11.6.3 Asia Systemic Antifungals Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Systemic Antifungals Revenue (2021-2032)
  2. 12.2 SAMEA Systemic Antifungals Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Systemic Antifungals Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Systemic Antifungals Revenue by Type (2027-2032)
  5. 12.3 SAMEA Systemic Antifungals Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Systemic Antifungals Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Systemic Antifungals Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Systemic Antifungals Revenue by Application (2027-2032)
  9. 12.5 SAMEA Systemic Antifungals Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Systemic Antifungals Revenue by Country
  11. 12.6.1 SAMEA Systemic Antifungals Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Systemic Antifungals Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Systemic Antifungals Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst